Advancing Approvals with Real-World Results

The FDA’s stance on RWE has evolved—and life sciences organizations are responding.

Inside the booklet, you’ll learn:

• How sponsors are using linked real-world data and natural history studies to meet FDA evidentiary standards

• Which approvals – from vaccine label expansions to rare disease breakthroughs – successfully leveraged RWE

• What types of study designs and external controls have proven successful in regulatory submissions

• How RWE supported label expansions, accelerated approvals, and rare-disease designations

• Key milestones from the FDA’s Advancing Real-World Evidence Program and recent guidance shaping the next generation of regulatory science